Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis
Christoph Roderburg(Universitätsklinikum Aachen), Tom Luedde(Medizinische Hochschule Hannover), Norbert Frey(University Hospital Schleswig-Holstein), David Vargas Cardenas(RWTH Aachen University), Alexander Koch(RWTH Aachen University), Mihael Vucur(Düsseldorf University Hospital), Frank Tacke(Medizinische Hochschule Hannover), David Scholten(RWTH Aachen University), Mark Luedde(Christian-Albrechts-Universität zu Kiel), Christian Trautwein(Medizinische Hochschule Hannover)
Cited by 158
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786